Preoperative Lanreotide Treatment Improves Outcome in Patients with Acromegaly Resulting from Invasive Pituitary Macroadenoma

By Li Z-Q   Quan Z   Tian H-L   Cheng M  

The Journal of International Medical Research, Vol. 40, Iss. 2, 2012-03 ,pp. : 517-524

Field House Publishing

Access to resources Recommend Favorite

Octreotide long-acting repeatable use among elderly patients with carcinoid syndrome and survival outcomes: A population-based analysis

By Shen Chan   Shih Ya-Chen Tina   Xu Ying   Yao James C.  

Cancer, Vol. 120, Iss. 13, 2014-07 ,pp. : 2039-2049

Blackwell Publishing

Access to resources Recommend Favorite

Primary Hepatic Carcinoid Tumours: Clinical Features with an Emphasis on Carcinoid Syndrome and Recurrence

By Zhang A   Xiang J   Zhang M   Zheng S  

The Journal of International Medical Research, Vol. 36, Iss. 4, 2008-07 ,pp. : 848-859

Field House Publishing

Access to resources Recommend Favorite

Ipilimumab before BRAF inhibitor treatment may be more beneficial than vice versa for the majority of patients with advanced melanoma

By Ascierto Paolo A.   Margolin Kim  

Cancer, Vol. 120, Iss. 11, 2014-06 ,pp. : 1617-1619

Blackwell Publishing

Access to resources Recommend Favorite

Surgical patients in Germany prefer oral anticoagulants

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 576, 2009-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite